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Abstract
Background: In the past decade, several transcription factors critical for pancreas organogenesis have been identified.
Despite this success, many of the factors necessary for proper islet morphogenesis and function remain uncharacterized.
Previous studies have shown that transgenic over-expression of the transcription factor Hnf6 specifically in the pancreatic
endocrine cell lineage resulted in disruptions in islet morphogenesis, including dysfunctional endocrine cell sorting,
increased individual islet size, increased number of peripheral endocrine cell types, and failure of islets to migrate away from
the ductal epithelium. The mechanisms whereby maintained Hnf6 causes defects in islet morphogenesis have yet to be
elucidated.
Methodology/Principal Findings: We exploited the dysmorphic islets in Hnf6 transgenic animals as a tool to identify factors
important for islet morphogenesis. Genome-wide microarray analysis was used to identify differences in the gene
expression profiles of late gestation and early postnatal total pancreas tissue from wild type and Hnf6 transgenic animals.
Here we report the identification of genes with an altered expression in Hnf6 transgenic animals and highlight factors with
potential importance in islet morphogenesis. Importantly, gene products involved in cell adhesion, cell migration, ECM
remodeling and proliferation were found to be altered in Hnf6 transgenic pancreata, revealing specific candidates that can
now be analyzed directly for their role in these processes during islet development.
Conclusions/Significance: This study provides a unique dataset that can act as a starting point for other investigators to
explore the role of the identified genes in pancreatogenesis, islet morphogenesis and mature b cell function.
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Introduction
Despite the recent success with islet transplantation as a
treatment for replacing insulin-producing b cells lost in individuals
with Type 1 diabetes [1], the relative shortage of donor tissue
necessitates the development of in vitro systems to grow functional
islets. Studies by various laboratories over the past several years
have resulted in the identification of several transcription factors
that function in normal pancreatic/islet cell development
(reviewed in [2]); however, much less is known about the cell
surface or extracellular components involved in islet formation and
function. Ultimately, the generation of optimally functioning islets
in vitro will likely rely on a complete understanding of how
transcription factor networks and cell-cell interactions regulate
proliferation, differentiation, and morphogenesis of normal
pancreatic endocrine cells.
During pancreas development, islets are formed through a series
of morphogenetic events involving cell migration, cell sorting, and
cell adhesion. Similar to Drosophila and mammalian neurogenesis,
pancreatic endocrine cells, of which islets are composed, become
committed to the endocrine cell lineage via the Notch signaling
pathway [3,4,5,6] and delaminate from the ductal epithelium. In
the mouse, the endocrine cells that will go on to contribute to the
mature islets of the adult organism first become apparent at
embryonic day (e) 13.5 and continue to form into early postnatal
stages [2]. Committed endocrine cells subsequently differentiate to
become five different hormone-producing cell types (b, a, d, e, and
PP cells). In the early stages of islet morphogenesis (around e17.5),
these hormone-expressing endocrine cells can be found in clusters
closely associated with the pancreatic ductal epithelium from
which they originate [7,8,9,10]. These endocrine clusters must lose
their tight association with the ductal epithelium and organize in
the acinar parenchyma to form typical islets [7]. The expression of
matrix metalloproteinases in endocrine cells (MMPs; known to be
involved in extracellular matrix degradation) is thought to aid in
the migration of these cells through basement membrane and
extracellular matrix [11]. There is also evidence that integrins may
be involved in guiding the migration and organization of the
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insulin-producing b cell core surrounded by a (glucagon), d
(somatostatin), e (ghrelin), and PP (pancreatic polypeptide) cells at
the periphery. In 2000, Cirulli et al. demonstrated that avb3 and
avb5 integrins could mediate the adhesion and migration of
putative endocrine precursors [12]. Despite these and other
studies, many of the processes involved in endocrine cell
migration/delamination and islet morphogenesis are not yet well
understood.
While many of the factors critical for islet morphogenesis remain
elusive, a role for cell adhesion molecules has been well described in
the formation of morphologically normal pancreatic islets. For
example, in transgenic mice, a dominant negative E-cadherin driven
specificallyto b cellsbythe rat insulinpromoter(RIP)leadstodefects
in b cell aggregation and islet formation [13]. In contrast, a cells
aggregated into clusters lacking b cells. Additionally, in animals with
a nullmutation inneuralcelladhesion molecule(NCAM),isletsform
with a cells randomly distributed throughout the islet rather than
being restricted to the islet periphery [14]. In NCAM mutant islets,
the subcellular distribution of epithelial polarity markers was also
disrupted, which suggests that NCAM may also be involved in cell
polarity and/or adhesion of islet cell types.
In addition to the mouse models mentioned above, transgenic
mice over-expressing the cut-homeodomain transcription factor
Hepatic nuclear factor 6 (Hnf6) specifically in the pancreatic
endocrine cell lineage showed disrupted islet morphogenesis and a
form of insulin-dependent diabetes [15]. Defects included aberrant
endocrine cell sorting, increased islet size, and failure of islets to
migrate away from the ductal epithelium. Due to the fact that
these Hnf6 transgenic animals exhibited common features of islet
dysmorphogenesis (scattering of islet cell types and abnormal islet
size) with the addition of the close apposition of islets to the ductal
epithelium, we hypothesized that these animals would serve as a
valuable tool in which to identify factors that are critical for
normal islet morphogenesis.
In the current study, whole genome microarray analysis was
performed on total pancreatic RNA to identify differences in the
gene expression profiles of wild type (WT) and Hnf6 transgenic
animals at late gestation (e18.5) and postnatal day one (P1),
developmental time points when the events of normal islet
morphogenesis are occurring [1]. Hnf6 transcription is dramati-
cally down-regulated in endocrine cells of WT animals at this time
and the protein is no longer detectable (Tweedie Ables et.al.,
submitted), thus magnifying the difference in Hnf6 activity for the
study. Additionally, these time points are well before the onset of
diabetes in the Hnf6 Tg mice ([15] and our unpublished
observations), and as such are not susceptible to alterations in
gene expression that are common to hyperglycemic animals
(reviewed in [16]). We provide the list of genes with altered
pancreatic expression in response to islet-specific HNF6 over-
expression. We discuss several genes that may be important for
normal islet morphogenesis and proper islet function.
Results and Discussion
Pdx1
PBHnf6 transgenic mice as a model of islet
dysmorphogenesis
Islet morphogenesis in the mouse begins around e17.5 and
continues postnatally. The formation of islets with the stereotypical
architecture of a b cell core surrounded by a, d, e and PP cells is
thought to be critical for the proper function of pancreatic islets
[17,18,19,20,21]. Despite the fact that many transcription factors
important for pancreas/islet development have been identified,
most of the factors critical for proper islet morphogenesis and
function remain uncharacterized.
We previously described a transgenic mouse model which
displayed alterations in islet morphogenesis [15,22]. In this model,
a 1.0 kb endocrine-specific enhancer (PB; [23]) from the 59
regulatory region of the pancreas and duodenal homeobox1(Pdx1) gene
was used to drive the expression of Hnf6 specifically to the
pancreatic endocrine lineage. Pdx1 is normally expressed in the
antral stomach, pancreas, and proximal duodenum and is essential
for pancreas development and mature b cell function
[24,25,26,27]. As Hnf6 is normally down-regulated in the
endocrine lineage prior to birth, the Pdx1
PBHnf6 transgene (Hnf6
Tg) allowed for the maintenance of Hnf6 expression in endocrine
tissue during late embryogenesis and continuing into adulthood
[15]. We found that maintaining Hnf6 expression in islets resulted
in a host of morphological and functional deficiencies, including a
scattering of cell types within the islets, abnormal islet size,
decreased insulin secretion, and a block to b cell maturation
(Figure 1; [15,22]). Additional morphometric analysis during
embryonic and perinatal development showed that islet compo-
sition is also altered in Hnf6 Tg mice. As seen in Figure 1C,
glucagon
+ cell area was increased in Hnf6 Tg embryos as early as
e15.5, and this increase was maintained postnatally (Figure 1C and
data not shown). The increase in glucagon
+ cell area was
manifested by larger glucagon
+ cell clusters that appeared to be
segregated from insulin
+ cells (Figure 1B*). Insulin
+ area was not
affected by the maintenance of Hnf6 until postnatal stages, at
which point a significant decrease in insulin
+ area as compared to
WT controls is observed (Figure 1C). As we have previously
shown, however, this mild decrease in the number of b cells does
not lead to the diabetes observed in this transgenic line [22].
Rather, defects in insulin granule biosynthesis and vesicle
trafficking cause the dramatic decrease in glucose stimulated
insulin secretion and ultimately, diabetes [22]. The time period of
embryonic glucagon
+ cell population expansion coincides with
previous reports of a dramatic increase in hormone-expressing
cells in normal pancreas tissue known as the secondary transition,
in which pro-endocrine cells that will mature to form the
functional units of the adult pancreas are thought to undergo
substantial differentiation and proliferation (for review, see [2]).
Since Hnf6 Tg animals exhibited islet dysmorphogenesis, we
reasoned that they would serve as an ideal model for the
identification of factors important for normal islet morphogenesis.
To gain a better understanding of the genes and genetic networks
that may underlie the processes of islet morphogenesis and
function, we performed a genome-wide microarray analysis,
profiling WT whole pancreas tissue versus whole pancreas
collected from Hnf6 Tg animals at late embryogenesis (e18.5)
and early postnatal (P1) stages. Whole pancreatic RNA has been
used by other investigators to examine changes in islet gene
expression at these same developmental stages [28]. These are
critical times in mouse islet development in which clusters of
hormone
+ cells can be observed to undergo a switch from being
randomly assorted to assuming the characteristic islet architecture.
Characterization of Gene Alterations in Hnf6 Tg animals
Gene expression profiles of WT and Hnf6 Tg pancreata at
e18.5 and P1 were generated using the Affymetrix GeneChip
Mouse Genome 430 2.0 array (a list of all raw data and
supplemental figures can be found at www.vmsr.net/supl/
mouse_islet). In addition, the data discussed in this publication
have been deposited in NCBIs Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and are accessible through
GEO Series GSE4926. All statistical analysis was performed using
GeneSpring 7.0 (Agilent Technologies). Since we were interested
in identifying transcripts differentially expressed due to their direct
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whole pancreas tissue was pooled (3–5 animals per pool) to
minimize differences associated with biological variability among
samples. To provide a robust technical assessment, this pool was
assayed in triplicate (see Methods). Technical replication allows
one to evaluate commonalities in gene expression changes and
does not reveal differences in gene expression that may be due to
inherent biological variability between individual animals, having
nothing to do with the genetic manipulation. Our initial
observations were subsequently validated independently on
individual samples for several of the gene products showing
altered expression in the pooled population (see below).
Gene expression ratio values were calculated by comparing signal
intensity values for each individual sample to the average signal
intensity value of the control or WT triplicates. This allows an
assessment of the consistency of the replicates and to compare gene
expression levels in WT and Hnf6 Tg pancreas at e18.5 (data not
shown) and P1 (Figure 2). Ratio values for all WT samples were
highly consistent with little sample-to-sample variability (Figure 2,
left).In the Hnf6Tgsamples plot(Figure2, right),the majorityofthe
genes remained centered around a ratio value of 1.0 (indicating no
change in expression); however, there were also subsets of genes with
ratio values greater than and less than 1.0, shown in red and blue,
respectively. These represent genes that have an altered expression
in Hnf6 Tg animals compared to WT animals.
As proof of principle, we were able to detect Hnf6 (Onecut1) itself
as up-regulated two-fold in the Hnf6 Tg mice as compared to WT
mice (Supplementary Material Tables S1 and S2). Since the model
used in these studies over-expresses Hnf6 specifically in endocrine
tissue and not in other pancreatic cell types, detection of altered
Hnf6 levels in whole pancreas from transgenic animals was crucial.
These data suggested to us that we were able to detect changes in
endocrine-specific gene expression using our experimental design.
Since Hnf6 levels were elevated only twice that of WT levels, it
appears that Hnf6 was not over-expressed at a super-physiological
level. However, since the islet cell population represents only about
20–30% of the total pancreatic mass at the stages examined, it
could be that the increase in Hnf6 expression within the islets is
actually higher than two-fold. The identification of changes in
expression of endocrine genes including Hnf6 was critical to our
analysis because we were interested in understanding changes
occurring within the islet cell population. Thus, we are confident
that we are able to detect changes occurring within a relatively
underrepresented cell type in the pancreas. We note that not all of
the observed changes in gene expression are likely to have
occurred solely within the endocrine tissue and acknowledge that
r
Figure 1. Hnf6 Tg animals exhibit abnormal islet morphogen-
esis. (A) Islet from a four week old WT animal showing insulin-
producing b cells at the islet core (green) and glucagon-producing a
cells at the periphery (red). (B) At the same age, individual Hnf6 Tg
islets are larger, have a mixed islet phenotype, and are closely apposed
to the ductal epithelium. (A*, B*) At e18.5, WT endocrine cells have
begun to adopt the stereotypic architecture; however, Hnf6 Tg a cells
are often clustered together in islet-like structures that have few, if any,
b cells (arrows in B*). (C) Morphometric analysis demonstrates
increased glucagon
+ cell area (red) as early as e15.5 in Hnf6 Tg islets
(dark red). This relative increase over WT islets (solid bars) persists into
postnatal stages. Total insulin
+ area decreases in transgenic animals
(dark green) at postnatal stages, but does not appear to be altered
during embryogenesis. e15.5, n=4; e18.5, n=4; P1, n=2; 2 weeks, n=3.
Error bars were determined by 95% confidence interval. *p,0.05,
**p,0.005, as determined by Student’s t-test. d, duct; bv, blood vessel.
doi:10.1371/journal.pone.0001611.g001
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expression due to over-expression of Hnf6 in islets.
To detect statistically significant differences in expression levels
between the WT and Hnf6 Tg pancreata, we performed t-tests,
using the Benjamini and Hochberg multiple testing correction to
improve the false discovery rate (the expected proportion of false
positives among the results. Lists of genes with a p-value of less
than 0.05 after this analysis were constructed (Supplementary
Material Table S1). A total of 1176 probesets were deemed
statistically significant by these criteria in the e18.5 data set along
with 484 probesets in the P1 data set. Importantly, genes of
particular interest to our study passed the test for statistically
significant differential expression. Onecut1 and its direct transcrip-
tional target Ngn3 [29] are both included in the t-test results and
thus showed a statistically significant difference in expression in the
Hnf6 Tg animals compared to WT, as did all of the transcripts
discussed in the following sections.
Microarray Validation
In order to validate results obtained using the microarray, we
chose several candidate genes for RT-PCR analysis. In these
studies, we used individual biological samples to confirm the
changes observed with technical replicates used for our microarray
studies. For validation purposes, we chose to examine several
transcripts that we considered potential factors involved in
pancreas development, but that have not been fully characterized
(Neuronatin, Reg2, Ectodin, and Serpina6), as well as transcripts that
were important for validation of our model (Hnf6, Pdx1). As
described, the model of islet dysmorphogenesis used for these
studies was islet-specific Hnf6 transgenic over-expression. Levels of
Hnf6 (Onecut1) were up-regulated at e18.5 and P1 by two-fold in
Hnf6 Tg pancreata on the microarray (Supplementary Material
Table S2B, D). Using RT-PCR on individual WT and Hnf6 Tg
pancreatic RNA extracts, we were also able to detect an increase
in Hnf6 transcript, albeit at slightly lower levels (Figure 3). As Hnf6
has been reported to directly activate Pdx1 early in pancreas
development, we predicted we might detect increased levels of
Pdx1 in Hnf6 Tg animals on the microarray. No change in Pdx1
expression was detected on the microarray and these results were
confirmed with RT-PCR.
Neuronatin (Nnat), a downstream target of the endocrine cell-
enriched transcription factor NeuroD/Beta2 was down-regulated
two-fold in Hnf6 Tg samples on the microarray. RT-PCR
validation on individual pancreatic RNA samples confirmed the
down-regulation of Nnat observed in Hnf6 Tg animals on the
microarray (Figure 3). Nnat is reported to be enriched in the b cell
line bTC1, and knock-down of Nnat in cell culture leads to
decreased insulin secretion in response to glucose [30,31].
However, the in vivo role for Nnat in pancreas development and
endocrine function remains unknown. Our results suggest a role
for Nnat in normal endocrine cell development.
Reg2 (Regenerating gene 2) belongs to the mitogenic Reg gene
family. In the pancreas, Reg2 has been identified in acinar tissue
and in hyperplastic islets [32]. Up-regulation of Reg2 has been
associated with diet-induced obesity, diabetes and regeneration
after partial pancreatectomy, and has also been suggested as a
compensatory mechanism for stimulating the proliferation of
pancreatic b cells and enhancing insulin secretion [33,34]. The
role of Reg2 in normal pancreas development has not been
investigated. Since Hnf6 animals have larger islets and overt
diabetes, we were interested in the up-regulation of Reg2 in Hnf6
Tg animals observed on the microarray (1.7-fold at P1). RT-PCR
analysis confirmed the up-regulation of Reg2 which was observed
in Hnf6 Tg animals via microarray analysis (Figure 3).
Figure 2. Assessment of replicate consistency and gene expression changes. Each line on the graph represents an individual spot on the
array. Normalized ratio values of the average for the three WT samples (WT1-WT3) were plotted against each individual WT sample (left) and each
individual Hnf6 Tg sample (right; Tg1-Tg3). Ratio values indicating no change in gene expression are seen in yellow at a value of 1.0. Transcripts that
have an altered expression in Hnf6 Tg animals compared to WT animals are indicated in shades of red (greater than 1.0) or blue (less than 1.0).
doi:10.1371/journal.pone.0001611.g002
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PLoS ONE | www.plosone.org 4 February 2008 | Volume 3 | Issue 2 | e1611Recent studies have shown that BMP signaling augments insulin
secretion from pancreatic b cells [35]. As Hnf6 Tg animals have
severe defects in insulin secretion, the observed up-regulation of
the secreted BMP inhibitor, Ectodin, on the microarray (1.6-fold at
e18.5; 1.9-fold at P1) was of interest. Since the role of BMP
signaling in islet function has only recently been appreciated,
Ectodin has not yet been studied within the context of islet function.
RT-PCR was used to confirm the up-regulation of Ectodin in Hnf6
Tg pancreata that was analyzed on the microarray (Figure 3).
Given its role as a BMP antagonist in other systems [36,37],
Ectodin should be investigated regarding its role in pancreatic
function.
Based on our interest in genes that may be involved in normal
islet morphogenesis, we chose to validate the alteration of Serpina6,
a member of the serine protease inhibitor family. Serpins are
involved in maintaining the integrity of the extracellular matrix
(ECM). ECM degradation and repair influence cell adhesion and
migration, all thought to be critical in islet morphogenesis. Its role
in the pancreas has not yet been described. Microarray analysis,
confirmed by RT-PCR (Figure 3), revealed that Serpina6 was up-
regulated 4.6-fold at P1 in Hnf6 Tg animals compared to WT.
EIF2A3 kinase (Perk) is involved in inhibition of protein
synthesis, and is involved in the ER stress response in pancreatic
b cells [38,39]. Studies have shown that Perk is expressed in b cells
and is specifically required in b cells during the fetal and early
neonatal period as a prerequisite for normal postnatal glucose
homeostasis [40]. Thus, as Hnf6 Tg animals have severe defects in
glucose homeostasis [22], it was of interest that microarray analysis
showed a two-fold down-regulation of PERK in these animals.
Validation of Perk down-regulation using RT-PCR showed non-
detectable levels of Perk in Hnf6 Tg animals, with much higher
levels in WT pancreata (Figure 3).
Gene Ontology Analysis
Gene ontology analysis was performed to classify genes
differentially expressed between the WT and Hnf6 Tg pancreata
(see Methods). Given the moderate sample size of the test groups
(n=3 per genotype) and the fact that low-abundance, differentially
expressed transcripts may be unable to reach significance without
additional replicates, the analyzed gene list was broadened to
encompass all genes showing at least a 1.5 fold-change in 2 of the 3
Hnf6 Tg replicate samples (Supplementary Material Table S2).
This allowed inclusion of candidate genes that did not reach
statistical significance but still showed a trend toward differential
expression between the WT and Hnf6 Tg samples. By this
criterion, a total of 1255 up-regulated probesets and 707 down-
regulated probesets were identified when both age groups were
considered. Of this gene set, 35 of the down-regulated genes were
common to both the e18.5 and P1 analysis, and 41 of the up-
regulated genes were common to both ages. A list of the genes
common to both ages can be found in Supplemental Material
(Table S3). The biological relevance of these trends in gene
expression changes will obviously need to be tested on an
individual basis. The only transcript of obvious significance to
pancreas development in this overlapping dataset was GATA4, a
known endodermal transcription factor, which was up-regulated in
the transgenic pancreata at both time points examined (2-fold at
e18.5; 1.5-fold at P1). Overall, the categories represented by
altered genes were congruent with the phenotypic alterations seen
in Hnf6 Tg animals [15,22].
Each gene was placed into one of 17 categories, which include:
protease/protease inhibitors, enzymes, cell adhesion, cytoskeletal
and ECM, signaling molecules, nucleic acid binding proteins,
membrane proteins, secreted proteins, vesicle proteins, blood
proteins, and cell cycle (Figure 4). Unknown genes were not
included in the analysis but comprised less than 40% of up or
down-regulated genes at either time point (unknown genes
represent a total of 39.5% of the 45,070 probesets on the
microarray). Since the completion of our original analysis, some of
these previously ‘‘unknown’’ gene products may subsequently have
been functionally characterized and ascribed to a particular
cellular process. These transcripts are also included in the entire
data set and may be obtained at www.vmsr.net/supl/mouse_islet.
At both time-points (e18.5 and P1), enzymes represented the
largest percentage of each group of altered genes (both up- and
down-regulated). This is representative of the complete probeset
present on the array, as enzymes constitute the largest group of
annotated genes (21.2% of 27,260). Based on the dysmorphic
phenotype of the Hnf6 Tg islets, we expected to see alterations in
factors involved in cell adhesion, cytoskeletal/ECM molecules,
and protease/protease inhibitors. These factors are known to be
involved in various aspects of islet morphogenesis, including
endocrine cell organization, degradation of basement membrane,
and delamination of endocrine cells away from ductal tissue
[7,9,10,11,12,41]. Indeed, we found that 18% and 22% of genes
altered at e18.5 and P1, respectively, can be categorized as cell
adhesion/cytoskeleton/ECM. In contrast, cell adhesion/cytoskel-
eton/ECM genes represent only 8.8% of annotated genes on the
array, suggesting that these genes in particular are up-regulated in
HNF6 transgenic pancreata.
Transcription factors. Approximately 20% of all annotated
transcripts that showed altered expression on the microarray were
categorized as nucleic acid binding proteins (Figure 4). This is
representative of the complete annotated probeset, in which
19.6% of all transcripts encode nucleic acid binding proteins. One
transcript of interest, the pro-endocrine transcription factor Ngn3
(Neurog3), was up-regulated two-fold at e18.5 by microarray
Figure 3. RT-PCR validation of microarray results. P1 pancreatic
WT (blue) and Hnf6 Tg (purple) RNA was analyzed for the expression of
the transcripts indicated. Values are expressed in arbitrary units as a
ratio (transcript:tubulin) of the average of individual samples for each
genotype. Error bars represent SEM; *p,0.05. n.d., not detectable. For
comparison, microarray analysis of these same transcripts revealed the
following: OC-1 increased two-fold; Pdx1 no change; Nnat decreased
two-fold; Reg2 increased 1.7-fold; Ectodin increased 1.6- to 1.9-fold;
Serpina6 increased 4.6-fold; PERK decreased two-fold.
doi:10.1371/journal.pone.0001611.g003
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tracing [42] and global deletion analyses [43] have shown that
Ngn3 is required for the differentiation of all endocrine cells in the
pancreas, and as such is one of the earliest transcription factors
that specifically marks the endocrine population prior to cell type-
specific hormone expression [44]. Previous research has shown
that Ngn3 is a direct target of Hnf6 transcriptional activity; global
Hnf6
2/2 mice have a dramatic down-regulation of Ngn3
+ cells
[29]. Furthermore, over-expression of Ngn3 within the Pdx1
+
domain results in an expansion of the endocrine population,
specifically in glucagon-producing cells [44]. Thus, the increased
numbers of glucagon
+ cells we observed in Hnf6 Tg pancreata at
e15.5, e18.5, and P1 (Figures 1C and 5B, E) may be due, in part,
to increased expression of Ngn3. We have used both western blot
and immunohistochemistry analyses to validate the up-regulation
of Ngn3 transcripts in Hnf6 Tg pancreata (Figure 5). These
experiments show that the number of Ngn3
+ cells at e15.5 and the
amount of Ngn3 protein at P1 (1.2 fold increase in Tg) is increased
in Hnf6 Tg pancreata (Figures 5C–E). This data correlates well
with the up-regulation of Ngn3 in the e18.5 microarray data set
(Supplementary Material Table S2B). Thus, over-expression of
Hnf6 specifically in the endocrine lineage results either in an
increase in the absolute number of Ngn3
+ endocrine progenitor
cells, or increases the duration of NGN3 expression in these cells.
Regardless of the mechanism, the effects of HNF6 over-expression
on Ngn3 expression are transient, as microarray analysis at P1
failed to show an increase in Ngn3 expression (Supplementary
Material Table S2D).
Microarray analysis of Hnf6 Tg animals also revealed a 1.7-fold
increase in the expression of the paired-homeodomain transcription
factor Pax6 (Supplementary Material Table S2B). Pax6 is known to
beimportantfornormal acelldevelopment/numberinthe pancreas
[45]. Therefore, its up-regulation in the Hnf6 Tg animals is not
entirely surprising due to the fact that both a cell number and
glucagon protein levels are increased in these animals at the time
when the microarray analysis was performed (Figures 1C and 5B).
Pax6 has also been shown to be altered in another study looking at
Hnf6 transcriptional regulation using rat insulinoma cells [46]; see
Conclusions). This may suggest that Pax6 is in some capacity regulated
(directly or indirectly) by Hnf6 in the rodent pancreas.
As a transcriptional activator, Hnf6 has been proposed to
directly transactivate Pdx1 [47]; however, microarray analysis of
Hnf6 Tg animals did not show a change in the expression of Pdx1.
Consistent with these results, immunohistochemistry for Pdx1 at
e18.5 (Figure 5A–B), failed to detect significant changes in the
number of Pdx1
+ cells in Hnf6 Tg pancreata. Likewise, no
significant alterations in the level of Pdx1 protein at P1 were found
by western blot analysis (Figure 5E). While we hypothesized that as
a direct activator of Pdx1, over-expression of Hnf6 could lead to an
increase in the number of Pdx1
+ cells similar to that seen for Ngn3,
our results are indeed consistent with mouse models of Hnf6 loss-
of-function. A previous report in the literature and additional
evidence from our lab has shown that early expression of Pdx1 is
delayed in models where Hnf6 expression is decreased or absent,
but Pdx1 expression levels normalize later in development [47];
Zhang et. al., submitted). These results suggest that Hnf6 may
positively regulate Pdx1 gene expression at early developmental
stages, but not at the stages used in our analyses. Alternatively, the
islet-specific pdx1 promoter fragment used to drive the transgene
may compete with endogenous regulators of pdx1 gene expression,
thus dampening the effect of HNF6 over-expression on the
endogenous pdx1 locus.
Cell adhesion and migration. Based on the fact that islets
over-expressing Hnf6 do not properly separate from ducts or
incorporate into surrounding acinar tissue, we were interested in
factors involved in cellular adhesion and migration and the
coordinated remodeling of extracellular matrix (ECM). Of
particular interest for this study were cell adhesion/migration
factors and/or proteases/protease inhibitors that were down-
regulated in the Hnf6 Tg animals. This may suggest that one or
more of these molecules are critical for the ‘‘movement’’ of islet
structures away from the ducts during islet morphogenesis, and its
down-regulation caused a disruption in the process. At P1 six cell
adhesion molecules were down-regulated, and one cell adhesion
molecule was up-regulated. Down-regulated cytoskeletal genes
include myosin, and kinesin family members.
Interestingly, several factors with altered expression in Hnf6 Tg
animals had previously been reported to be involved in
modulating cell adhesion and migration or remodeling of the
ECM. Such molecules include: Matrix metalloproteinases (MMP) 8
(1.7-fold down-regulated at e18.5) and 14 (1.6-fold up-regulated at
e18.5), and the protease inhibitors Timp3 (1.9-fold up-regulated at
e18.5) and Serpina1 (1.5-fold down-regulated at e18.5), all known to
be involved in the remodeling of extracellular matrix; and A
disintegrin and metalloprotease (ADAM) family members 10 (1.6-fold
Figure 4. Relative proportion of transcripts altered in Hnf6 Tg
animals as determined by gene ontology analysis. Known
transcripts altered by 1.5-fold or greater were placed into one of 16
categories, represented by specific colors on each chart. (A) Transcripts
up-regulated at e18.5 (total 582). (B) Transcripts down-regulated at
e18.5 (total 283). (C) Transcripts up-regulated at P1 (total 135). (D)
Transcripts down-regulated at P1 (total 161).
doi:10.1371/journal.pone.0001611.g004
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Proteases and protease inhibitors comprise only 0.9% of all
annotated sequences of the array, while they represent: 3.5% of
genes down-regulated at e18.5, 1.7% of genes up-regulated at
e18.5, 2.5% of genes down-regulated at P1, and 3.7% of genes up-
regulated at P1. Thus, as with cell adhesion and ECM molecules,
these types of genes are specifically increased by HNF6 over-
expression.
Connective tissue growth factor (CTGF), a secreted factor which binds
to integrins and elicits a variety of biological responses in various
tissues, including cell migration [48] was down-regulated 2.5-fold
at P1. Preliminary data from our laboratory indicates that loss of
CTGF results in defects in islet morphogenesis similar to those
seen in the HNF6 Tg animals, and decreased embryonic b cell
proliferation (Crawford et. al. submitted).
We also identified many genes that have been characterized to
be involved in morphogenetic processes in neurons. Pancreatic
endocrine cells have many molecular similarities with neuronal cell
types, such as: 1) developmental requirement for the same
transcription factors or closely related family members
[43,49,50,51,52,53,54]; 2) involvement of the Notch signaling
pathway in progenitor allocation [3]; and 3) the deposition of
amyloid in disease states such as Alzheimer’s and Type 2 diabetes
[55]. Examples of genes altered in the Hnf6 Tg animals that have
been implicated in cell migration in the brain include: Abi2 (1.7-
fold down-regulated at e18.5), an adaptor protein which, when
inactivated, results in abnormal lens fiber migration in the eye
(Supplementary Material Table S2A; [56]); Stathmin (Stmn)( ,1.7-
fold down-regulated at e18.5 and P1), a microtubule-associated
protein whose over-expression leads to increased motility of
GnRH neurons (Supplementary Material Table S2A; [57]); and
Neogenin (Neo1) (1.9-fold down-regulated at e18.5), a protein
expressed in the extending fiber cells of the developing lens,
implicating it in migration events of these fibers (Supplementary
Material Table S2A; [58]). Neogenin has also recently been reported
to be localized to the developing pancreatic epithelium, strength-
ening the possibility of its involvement in pancreatic islet
morphogenesis [59].
Cell proliferation. Prompted by reports regarding the role of
Hnf6 in the proliferation of hepatocytes [60] and the binding of
Hnf6 to the proximal promoter regions of several known cell cycle
regulators in both liver and pancreas [61], we examined our
microarray data for changes in the expression of cell cycle genes in
Hnf6 Tg animals. Interestingly, we found that cell cycle genes
were more likely to be up-regulated by 1.5-fold or higher at e18.5
and P1 than down-regulated (2.2% up-regulated at both e18.5 and
P1; 1.4% and 1.2% down-regulated at e18.5 and P1, respectively).
We detected alterations in several known cell cycle regulators,
many of which have been implicated in postnatal b cell replication:
Cyclin D1 (1.8-fold up-regulated at e18.5), Cyclin D2 (two-fold up-
regulated at e18.5), Cyclin G1 (1.5-fold up-regulated at e18.5), and
Cyclin B2 (1.6-fold up-regulated at P1); Menin (1.7-fold up-regulated
at e18.5); p21 (1.9-fold up-regulated at e18.5); and p57 (1.5-fold
down-regulated at P1) (Supplementary Material Table S2;
[62,63,64,65]). Thus, we have provided evidence that several
cell cycle regulators are impacted by the maintained expression of
Hnf6. This correlates well with previous reports of Hnf6
interaction with cell cycle genes, such as the key cell cycle
regulator FoxM1 [60].
We hypothesized that increased proliferation of glucagon
+ cells
could contribute in part to the increase in this cell type. As
significant increases in the number of hormone
+ cells can normally
be detected between e14.5 and e16.5 [2], we analyzed pancreata
from e15.5 embryos for co-localization of either glucagon or
insulin with phosphorylated histone H3 (p-H3), a marker of
mitosis, by immunofluorescence (Figure 6). Indeed, there was a
Figure 5. Immunofluorescent and western blot validation of microarray results for Hnf6 transcriptional targets. No changes in Pdx1
expression (red) were observed by co-immunohistochemistry in e18.5 WT (A) and Hnf6 Tg (B) embryonic pancreata (glucagon shown in green). In
contrast, Increased numbers of Ngn3
+ cells (green) were observed within the pancreatic epithelium (outlined) at e15.5 (glucagon
+ cells shown in red)
in HNF6 Tg pancreata (C) as compared to WT pancreata (D). P1 pancreatic extracts (E) were probed for the expression of the proteins indicated.
Values are expressed as a ratio (WT:Hnf6 Tg). Two representative samples for each genotype are shown.
doi:10.1371/journal.pone.0001611.g005
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+/p-H3
+ cells in Hnf6 Tg embryos
as compared to WT littermates, while no difference was detected
in proliferation of insulin
+ cells at this time. No significant changes
in proliferation could be detected in glucagon
+ or insulin
+ cells at
e18.5 or P1 (Figure 6C).
Insulin granule biosynthesis and secretion. In order to
secrete insulin in response to changes in blood glucose
concentration, b cells are highly specialized to coordinate
protein synthesis and modification with Ca
2+-sensitive regulated
exocytosis (for review, see [66,67]. To this end, a readily-releasable
pool of insulin protein is stored in the cytoplasm within dense-core
secretory vesicles (‘‘granules’’). Upon glucose stimulation,
membrane depolarization by K
+-ATP channels triggers an influx
in Ca
2+ via L-type Ca
2+ channels. Proteins such as synaptotagmins
are then thought to act as Ca
2+ sensors that initiate the assembly of
the basic fusion machinery as well as the mobilization of insulin
granules (‘‘priming’’) for exocytosis.
We previously showed that Hnf6 Tg animals have impaired
glucose-stimulated insulin secretion (GSIS) and post-weaning
hyperglycemia, as well as significant decreases in levels of the
glucose transporter GLUT2 [15]. Subsequent analyses revealed that
defects in insulin secretion may be attributable to altered insulin
granule maturation, trafficking, and release [22]. Most strikingly, b
cells from Hnf6 Tg animals at six weeks of age have a dramatic
reduction in all insulin granules, correlating with a loss of
secretagogue-stimulated insulin secretion. These cellular alterations
are consistent with late postnatal alterations in protein trafficking,
either within the trans-golgi network (TGN) or in the maturation,
shuttling, and ultimate exocytosis of insulin granules from the b cell.
Microarray analysis at both e18.5 and P1 showed alterations in
gene expression at all levels of insulin exocytosis, including: protein
synthesis, protein modification and packaging, vesicle maturation,
granule exocytosis, and post-exocytosis vesicle recycling. One
example, the Vacuolar-type H
+-ATPase (V-ATPase or ATP6V0A1; 1.8-
fold up-regulated at e18.5), localized to both the TGN and
granules in secretory cells, is thought to provide the proper pH for
processing and acidification/maturation of insulin granules
(Supplementary Material Table S2B; [68]). Several transcripts
altered in our analysis, including the granule-localized Granuphilin
(1.5-fold down-regulated at P1), Cellubrevin (VAMP3) (1.6-fold up-
regulated at e18.5), Rab3d (1.6-fold up-regulated at e18.5), and
Rab27a/b (1.7-fold up-regulated at e18.5), have each been
implicated in granule fusion to the plasma membrane in
preparation for exocytosis [69,70,71,72,73]. Similarly, the plasma
membrane-localized Synaptotagmin 7, down-regulated 1.5-fold at
P1, is thought to be important for targeting exocytosis machinery
to specific localization points on the plasma membrane (reviewed in
[67]). Furthermore, both Rab3a and Rab27a/b appear to play
important roles specifically in b cell regulated exocytosis [73,74].
The Rab family members are GTP-binding proteins that appear to
function as regulators of the secretory and endocytic pathways. Rab3
and 27 are predominately localized to granules of neuroendocrine
secretorycells,and useeffectorproteinssuchas Granuphilinto move
granulesviatheunconventionalMyosinVa(down-regulated1.5-fold
at e18.5) along the actin cytoskeleton to the plasma membrane for
exocytosis (Supplementary Material Table S2; [69,75,76]). Lastly,
the CDK5 inhibitor CDK5RAP1 (C42; up-regulated 2.1-fold at P1)
has also been recently implicated in the regulation of this process
(Supplementary Material Table S2D; [77,78,79]), though a
thorough in vivo analysis of this inhibitor’s role in insulin granule
exocytosis has not yet been performed.
Although it is still not known whether any of these genes are
direct targets of Hnf6, Hnf6 Tg mice may provide a new model for
understanding how changes at the transcriptional level can alter
the processing and exocytosis of insulin, and how these defects
ultimately lead to changes at the physiological level (i.e., diabetes).
Conclusions
The prospect of generating optimally functioning islets in vitro
will likely rely on a complete understanding of how transcription
factor networks and cell interactions regulate proliferation,
differentiation, and morphogenesis of normal pancreatic endo-
crine cells. Although many transcription factors critical for these
processes have been identified and characterized, information
about genes involved in islet morphogenesis has remained rather
elusive. In order to take an unbiased approach to the identification
of previously unappreciated islet morphogenetic factors, we
genetically profiled a model of islet morphogenesis from our
laboratory. The Hnf6 Tg animals were previously reported to
have diabetes and islet dysmorphogenesis, characterized by a
mixed islet phenotype and islets with close apposition to ducts
[15]. Since microarray analysis generates vast amounts of data, the
resulting data were categorized based on the functional role of
each altered transcript. Of primary interest to us were genes
involved in the processes predicted to be critical for islet
morphogenesis (cell adhesion, cell communication, cell migration,
ECM degradation, and cell sorting). In fact, we found that these
classes of genes were disproportionately represented in our list of
altered genes when compared with their representation in the total
probeset present on the microarray.
There have been few studies addressing potential transcriptional
targets of Hnf6 in the pancreas. In one study, Odom and
colleagues constructed custom DNA microarrays targeting geno-
mic regions located 700 base pairs upstream and 200 base pairs
downstream of transcription start sites [61]. They subsequently
performed chromatin immunoprecipitation combined with pro-
moter microarrays in order to identify genes occupied by Hnf6 in
isolated adult human pancreatic islets. The primary interest in the
present study was not to identify direct binding targets of Hnf6,
but rather to use the Hnf6 Tg animals as a tool for the
Figure 6. Increased proliferation of glucagon
+ cells in Hnf6 Tg
pancreata. Proliferation rates in WT (A) versus Hnf6 Tg (B) pancreata
were determined by co-immunohistochemistry for phosphorylated
histone H3 (p-H3, red) and either glucagon (green) or insulin (data not
shown). (C) Number of cells that co-expressed p-H3 and either
glucagon or insulin are expressed as a percentage of the total
hormone
+ cells counted at e15.5, e18.5, and P1; **p=0.004.
doi:10.1371/journal.pone.0001611.g006
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the two studies are quite different in nature, comparison of the
data sets reveals 16 genes in common between the two studies as
well as similar, but not identical, gene products. For example,
Connexin32, Hnf4, and Meis1 as well as Claudin, Serpin, and Sec-like
family members were identified in both studies (Supplementary
Material Table S2; [61]). Therefore, the information provided in
the Odom study suggests that these genes are also direct targets of
Hnf6 during islet morphogenesis (e18.5 or P1). The remaining
genes identified in the present study, but not found in the Odom
analysis, are likely to be a combination of 1. indirect targets, 2.
direct targets where Hnf6 binds outside the proximal promoter
region, 3. genes that are direct Hnf6 targets during islet
morphogenesis but are not expressed in the adult cultured islets,
and 4. genes that are secondarily altered due to changes in non-
endocrine cells within Hnf6 transgenic pancreata.
Inanother study,aninducible Hnf6transgene wasintroduced into
INS-1 cells [46]. Microarray analysis of INS-1 cells induced with
tetracycline to express HNF6 revealed changes in gene expression
patternsinsomegenesincommonwithouranalysis.Genescommon
to both studies include: Onecut1 (Hnf6), Met, Ddc, C1galt1, Dig1, Iapp,
Pax6,Gnas,an dGhr (SupplementaryMaterialTableS2;[46].Itisnot
surprising that there are only a small subset of overlapping genes
between our analysis and the Thomas analysis, due to some major
differences in study design. For example, our study used a mouse
Affymetrix chip with RNA from in vivo whole mouse pancreas, while
the Thomas paper used a rat platform with RNA from a pancreatic
b cell line (isolated from rat insulinoma). While these studies were
performed to revealdifferent information,comparing data acrossthe
three can help to shed new light on the similarities and differences in
the numbers and types of genesHnf6regulates (directly or indirectly)
in different organisms and cell types.
Microarray analysis provides an opportune method for compar-
ing, on a large scale, changes in gene expression that result from
singlefactormanipulations.Wehypothesized thatusingtheHnf6Tg
mouse as a model for islet dysmorphogenesis would provide an
excellent tool for identifying new genes involved in the cellular
processes that establish endocrine pancreatic morphology and
architecture. We have identified a host of new gene targets, many
of which have not been characterized in the pancreas or in the
process of islet morphogenesis. Using this data, perhaps in
combination with information gained from future microarray
analyses of other mouse models, may help to dissect and understand
the regulatory networks involved in pancreatogenesis, ultimately
leading to a complete picture of how islet architecture contributes to
the finely tuned function of endocrine cell types.
Materials and Methods
Animals
Hnf6 expression was driven specifically to pancreatic endocrine
cells beginning at e11.5 using a 1.0 kb islet enhancer (22642 to
21654) from the 59 Pdx1 mouse promoter region as previously
described [15]. This transgenic line, termed Pdx1
PBHnf6, was
maintained on an inbred hybrid (B6D2) background. All mice
were kept on a 12 hour light/dark cycle, fed Mouse diet 5015
(LabDiet), and given water ad lib. For embryonic analyses, the
morning of the vaginal plug was considered e0.5.
All mouse studies were performed in accordance with the
Vanderbilt Institutional Animal Care and Use Committee
guidelines under the supervision of the Division of Animal Care.
Tissue acquisition and RNA isolation
Pancreata were dissected at e18.5 and P1 in ice cold PBS and
immediately placed into RNAlater (Ambion). RNA from whole
pancreas was isolated using the RNAqueous RNA Isolation Kit
(Ambion) according to the manufacturer’s instructions. Agilent’s
Bioanalyzer microfluidic assay (Agilent Technologies, Palo Alto
CA) was used to assay RNA integrity (Supplemental Figure S1).
Spectrophotometric and fluorometric methods were combined to
quantitate protein and nucleic acids present in the sample, and to
ensure quality control of each sample. RNA samples were
bioanalyzed individually to assess RNA quality and integrity.
Highly pure samples were pooled according to their genotype (3-5
animals per pool) in order to obtain an adequate quantity of RNA.
Supplemental Figure S1 shows the results for individual and
pooled samples at e18.5, but similar results were obtained at P1.
Microarray Analysis
Following quality control, the RNA was prepared for microarray
analysis using the standard Affymetrix protocol (Affymetrix Inc,
Santa Clara, CA). Briefly, a total of 5 mg of total RNA was reverse
transcribed to double-stranded (ds) cDNA using an oligo-dT primer
coupled to a T7 promoter. In vitro transcription from the ds cDNA
was then carried out using T7 polymerase and incorporating biotin-
modified CTP and UTP ribonucleotides. The biotinylated cRNA
(15 mg) was fragmented and hybridized in triplicate to Affymetrix
GeneChip Mouse Genome 430 2.0 arrays containing 45,000 sets of
11 to 25-mer oligomers, representing 39,000 mouse transcripts
(34,000 are annotated as well-defined genes). Hybridized cRNA was
detected using streptavidin coupled to phycoerythrin and visualized
by the Affymetrix 3000 7G laser scanner. The image data was
quantitated to generate gene expression values and ratios of gene
expression between the hybridized samples. For statistical analysis,
CEL files (raw Affymetrix data) were processed using GeneSpring
7.0 (Silicon Genetics) and normalized using Robust Multi-array
Analysis (RMA; [80]). T-tests using the Benjamini and Hochberg
multiple testing correction were performed on the data to identify
genes differentially expressed between the two groups with a
significance score of less than 0.05. Statistically significant differences
ingene expression between WT pancreas and HNF6pancreas tissue
were confirmed using RT-PCR, western blot and immunohisto-
chemistry. Gene ontogeny analyses were performed using the
annotations provided in the GeneSpring 7.0 program. Gene
products not annotated in the GeneSpring program were manually
investigated individually using Unigene on the NCBI website
(http://www.ncbi.nlm.nih.gov/sites/entrez) to determine whether
the gene had been ascribed a particular function or found to be part
of a known metabolic pathway.
Tissue preparation and histology
Digestive organs or isolated pancreata from varying embryonic
and adult stages were dissected in PBS and fixed immediately in
4% paraformaldehyde (4uC; 45–60 min). Tissues were dehydrated
in an increasing ethanol series followed by two xylene washes,
infiltrated with xylene:paraffin (1:1, v/v) and two changes of
paraffin at 56uC, and embedded for sectioning.
Serial 5 mm sections were deparaffinized and rehydrated in a
decreasing ethanol series to distilled water. Indirect protein
localization was obtained by incubation with the following primary
antibodies: guinea pig a-insulin (1/1000, Linco), rabbit anti-
glucagon (1/1000, Linco), rabbit anti-phosphohistone H3 (1/50,
Upstate Biotech), rabbit anti-Pdx1 (1/1000, a gift of C. Wright,
Vanderbilt University), and guinea pig anti-Ngn3 (a gift of M.
Sander, UC Irvine). All primary antibodies were incubated
overnight at 4uC in a humidified chamber. Detection of
phosphohistone H3 (pH3), Pdx1, and Ngn3 required antigen
retrieval in either citrate buffer (pH3, Pdx1) or TEG buffer (Ngn3)
and previously described [22]. Primary antibodies were detected
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Cy2 or Cy3 fluorophores (1/500, Jackson Immunoresearch).
Fluorophores were excited using either an Olympus BX41
research microscope or a Zeiss LSM 510 confocal microscope.
TIFF images were captured using MagnaFire software (Optro-
nics). Image tonal range and color balance were minimally
adjusted via histogram using Adobe Photoshop. Proliferation
studies were performed on a minimum of three individual animals
at each time point for each genotype.
Morphometric analysis of endocrine cell and total islet area
Paraffin sections from two to four animals per genotype per age
(at least 150 islets total per category) containing endocrine tissue
were chosen at random intervals along the length of the pancreas
(see Figure 1 legend for actual numbers). Following immunoflu-
orescent detection of insulin and glucagon, Metamorph morpho-
metric software (Universal Imaging) was used to measure the
approximate area on each section occupied by either insulin (green
channel) or glucagon (red channel) by manual thresholding of
pixel intensity. Data were then expressed as a percentage of
insulin
+ or glucagon
+ area to the total endocrine area measured.
Statistical analysis was performed by two-tailed Student’s t-test
using Excel software.
Protein extraction and western blotting
Western blot analysis was used to validate specific microarray
candidates in individual pancreatic protein extracts. Embryonic
pancreata were dissected and immediately placed into extraction
buffer containing a protease inhibitor cocktail (0.5 mg/L TPCK,
0.5 mg/L TLCK, 0.6 mM leupeptin, and 2 mM pepstatin), DTT,
and PMSF (detailed protocol provided upon request). Samples were
homogenized with a small volume motorized pestle, centrifuged to
remove cellular debris, and the supernatant frozen at 280uCf o r
long-term storage. Protein was quantitated by the Bio-Rad DC
protein assay according to manufacturer’s instructions.
Protein was electrophoresed on either 10–20% Tris-glycine gels
or 4–12% Bis-Tris gels under denaturing conditions, and blotted
to PVDF membrane using the NuPAGE western blotting system
(Invitrogen). To ensure equivalent amounts of total protein were
loaded per lane, blots were stained briefly with Ponceau S (Sigma).
Blots were then blocked in 5% non-fat milk in TBS (pH 7.6) for
one hour at room temperature and probed with the following
primary antibodies diluted in 3% non-fat milk in TBS and
incubated overnight at 4uC: rabbit anti-Pdx1 (a gift of C. Wright,
1/1000), rabbit anti-Ngn3 (Abcam, 1/1000), goat anti-b-actin
(Santa Cruz, 1/5000). Rabbit anti-glucagon (Linco, 1/500) was
also used to probe blots, but required blocking in 20% non-fat milk
in TBS (pH 7.6) overnight at 4uC, and incubation in primary
antibody diluted in 5% non-fat milk for one hour at 4uC. Blots
were washed in 0.05% Tween-20 in TBS for 30 minutes at room
temperature with three changes of buffer. HRP-conjugated
species-specific secondary antibodies were diluted to 1/2000
(anti-goat IgG, Santa Cruz) or 1/5000 (anti-rabbit IgG, Amer-
sham) in 1% non-fat milk in TBS and incubated for one hour at
room temperature. Following washes as previously described,
protein detection was facilitated by the ECL detection system
(Amersham) per manufacturer’s instructions using Kodak X-Omat
Blue film. Protein levels in individual pancreata were then
quantitated on a Molecular Imager FX densitometer (Bio-Rad)
using Quantity One 4.6 software (Bio-Rad) and normalized to the
quantity of b-actin obtained for each sample. Protein levels are
thus illustrated as a ratio of WT:Hnf6 Tg. For Pdx1 the density of
all three bands (includes both unmodified and post-translationally
modified forms of the protein) was included in the quantitation.
Semi-quantitative reverse transcriptase PCR
RNA was isolated from individual pancreata at P1 as described
above. Samples were DNase treated to remove contaminating
genomic DNA per the manufacturer’s instructions (Ambion). cDNA
synthesis was performed on individual wildtype (n=3–4) and HNF6
Tg (n=3–4) using Applied Biosystems reverse transcription reagents
according to the manufacturer’s instructions.
Pancreatic mRNA expression was analyzed by PCR (30 cycles of
amplification) using intron-exon boundry spanning primers with the
following sequences: PERK fwd: gttgctgattggaaggtcat; PERK rev:
agtcgtatttactttcagtct; OC1 fwd: cagcgaccttgcaggaat OC1 rev:
gctttcagctttgcctcct; Pdx1fwd: aagctcacgcgtggaaag;Pdx rev: gccggga-
gatgtatttgttaaa; Serpina6 fwd: ccctcatcctgatcaactacatc; Serpina6 rev:
tcattcacatagaagtcctcctctc;R e g 2fwd: aattgaagaccgtttgacctg; Reg2 rev:
gacctgcattcatgttctgg; Nnat fwd: cacccactttcggaaccat; Nnat rev:
tgcagcattccaggaaca; Ectodin fwd: aacagcaccctgaatcaagc; Ectodin
rev: cagcccacttgaactcgac
Transcript levels in individual pancreata were quantitated on a
Molecular Imager FX densitometer (Bio-Rad) using Quantity One
4.6 software (Bio-Rad) and normalized to the quantity of tubulin
for each sample. All values for individual transcripts were
normalized to tubulin expression. Data are expressed as a ratio
of transcript to tubulin in arbitrary units.
Supporting Information
Figure S1 Bioanalysis of individual and pooled RNA samples
used for microarray analysis at e18.5. (A) The samples were
quantified in 10mM Tris on a Nanodrop ND-1000 Spectropho-
tometer. In addition to concentration, this instrument reports the
260/280 absorption ratio, which can be an important indicator of
hidden contaminants. RNA integrity was assessed on total RNA
isolated from individual pancreata at e18.5 using microfluidic
analysis. The electropherogram it produces makes it easy to detect
certain contaminants or degradation, and to calculate the 28s:18s
ratio. Intensity and clarity of 28s and 18s ribosomal RNA bands
(indicated) was used as a measure of RNA quality in addition to
the lack of degradation products below the 18S band. The far left
lane is the molecular weight ladder. Lanes 2, 3, 5, 7, and 8
represent total pancreatic RNA isolated from HNF6 transgenic
animals. Lanes 1, 4, 6, and 9 represent total pancreatic RNA
isolated from wild type littermates. For microarray analysis, RNA
from all transgenic samples were pooled (5 total), while samples 1,
4, and 9 were pooled (3 total) to generate wild type RNA. Sample
number 6 was discarded due to the increased presence of
degradation products in this sample. (B) Bioanalysis results from
the pooled wild type samples (lane 1) and pooled transgenic
samples (lane 2). These samples were labeled and used for
microarray hybridization. Lane 3 is the molecular weight ladder.
Found at: doi:10.1371/journal.pone.0001611.s001 (0.46 MB
DOC)
Table S1 Statistically significant transcripts altered in Hnf6 Tg
pancreata. Complete list of transcripts down- (A, C) or up-
regulated (B, D) at e18.5 (A, B) or P1 (C, D) with a p value of
,0.05 as determined by Benjamini and Hochberg (variance
unequal) statistical analysis.
Found at: doi:10.1371/journal.pone.0001611.s002 (0.38 MBXLS)
Table S2 Transcripts altered by 1.5-fold or greater in Hnf6 Tg
pancreata. Complete list of transcripts down- (A, C) or up-
regulated (B, D) at e18.5 (A, B) or P1 (C, D) with a change in
expression of 1.5-fold or greater.
Found at: doi:10.1371/journal.pone.0001611.s003 (0.42 MB
XLS)
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in Hnf6 Tg pancreata. Down- (A) and up-regulated (B) genes
common to both e18.5 and P1 data sets as determined by a change
in gene expression of 1.5-fold or greater.
Found at: doi:10.1371/journal.pone.0001611.s004 (0.03 MB
XLS)
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